View Clinical Trial (Medical Research Study)

Reducing Sleep Disparities in Urban, Minority School-Aged Children

This study is not currently recruiting Study Participants on If you would like to find active studies please search for clinical trials

Browse Studies

City:   New York
State:   New York
Zip Code:   10032
Conditions:   Sleep
Purpose:   Inadequate sleep is a major health problem of childhood that often fails to receive attention until significant neurobehavioral and other health problems are noted. Although adequate sleep is essential for normal growth and brain development, studies show that children from minority and economically disadvantaged families are more likely to experience shorter sleep times and more sleep fragmentation compared to their Caucasian and economically advantaged counterparts. As a result, they are disproportionately affected by the adverse health and quality of life consequences of poor sleep. There are currently no intervention studies to the investigators knowledge aimed at addressing sleep disparities by improving sleep duration and sleep hygiene in early school-aged children from minority populations. This study seeks to close the 'sleep gap' that exists between the sleep duration of minority school-aged children and that of their non-minority peers. An interdisciplinary team of researchers and clinicians from Columbia University's Pediatric Lung and Sleep Disorders Center, School of Public Health, Psychiatry Department, and two outpatient clinic systems affiliated with Columbia are collaborating to reduce sleep disparities by improving sleep duration in a group of 5-6 year old minority children. The primary goal of this study is to evaluate the efficacy of a tailored, interactive, educational and behavioral intervention that utilizes trained sleep counselors to assist parents in improving their children's sleep hygiene and reducing risk factors for poor sleep, thereby increasing sleep duration over a 12-month period in a randomized controlled trial of children identified with sleep problems (Aim 1). The investigators will screen 375 parents of 5-6 year old children from 5 primary care clinics to identify children with and without sleep problems and enroll 90 of the 375 children screened who have sleep problems in a randomized controlled trial of an in-home sleep intervention. Using an initial home assessment, baseline actigraphy data, sleep logs recorded by parents, and information regarding risk factors for poor sleep collected from each family during screening, the investigators will work with intervention parents to develop a personalized sleep plan for their children. The investigators will evaluate the effect of the intervention on: a) nightly sleep duration; b) neurocognitive function; and c) behavioral disorders.
Study Summary:   Inclusion Criteria. Eligible families must: (1) have a typically developing healthy child age 5-6 years old enrolled in school for a minimum of 5 hours per day; (2) have a child who screens positive for a sleep problem based on the CSHQ (a score >41); (3) have lived in permanent housing within the catchment communities for the study (not in a shelter or other temporary housing) for the previous 12 months; (4) have no plans to move out of the area in the next 12 months; (5) agree to have research staff come into their homes for a home assessment and actigraph fitting every 3 months for 1 year; (6) have telephone access or a contact with telephone access; and (7) be fluent in either English or Spanish. Exclusion criteria will include the presence of a serious co-morbid condition in the child that may impact sleep including: genetic syndromes, neuromuscular disorders, seizure disorder, mental retardation, autism, severe learning disabilities, psychiatric disorders, and attention-deficit/hyperactivity disorder. The presence of such co-morbid conditions would confound the outcome of interest.
Criteria:   Inclusion Criteria: - Healthy child age 5-6 years old - School enrollment for a minimum of 5 hours/day - Positive Children's Sleep Habits Questionnaire (score ≥ 41) - Permanent housing for the previous 12 months - Permission for research staff to complete 5-9 home over 1 year - Have telephone access or a contact with telephone access - Fluent in either English or Spanish Exclusion Criteria: - Serious co-morbid condition that may impact sleep including: - genetic syndromes - neuromuscular disorders - seizure disorder - mental retardation - autism - severe learning disabilities - psychiatric disorders - attention-deficit/hyperactivity disorder
NCT ID:   NCT01301989
Primary Contact:   Principal Investigator
Beverley J Sheares, MD, MS
Columbia University

Backup Contact:   N/A
Location Contact:   New York, New York 10032
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:
Date Processed:   August 29, 2014
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


    (updated 33 minutes ago)
Within 25 Miles

Endometriosis - New York NY

Endometriosis - New York NY

Gout - New York NY

Pediatric Type 2 Diabetes (Ages 10-17) - New Hyde Park NY

Multiple Sclerosis (Relapsing) - Plainview NY

Depression - New York NY

Diabetes - New York NY

Obsessive Compulsive Disorder (OCD) - New York NY

Heart Failure After Heart Attack - New York NY

Heart Failure After Heart Attack - New York NY

Type 2 Diabetes - Massapequa NY

Postherpetic Neuralgia - New York NY

Social Anxiety Disorder - New York NY

Depression - New York NY

Adult ADHD - New York NY

Depression - New York NY

Chronic Obstructive Pulmonary Disease (COPD) - New York NY

Diabetic Nephropathy (Kidney Disease) - New York NY

Major Depression Disorder - New York NY

PBA - Pseudobulbar Affect - New York NY

Obsessive Compulsive Disorder (OCD) - New York NY

Gout - Lodi NJ

Parkinson's Disease - New York NY

Type 2 Diabetes - Rosedale NY

Type 2 Diabetes - Lodi NJ

Type 2 Diabetes - Brooklyn NY

Type 2 Diabetes - Staten Island NY

Fibromyalgia Pain - New York NY

Attention Deficit Hyperactivity Disorder (ADHD) - New York NY

High Cholesterol - Linden NJ

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - New York NY

High Cholesterol - Brooklyn NY

Endometriosis - Staten Island NY

Asthma in Children (Ages 5-11) - Verona NJ

Alzheimer's Disease - New York NY

COPD (Emphysema and Chronic Bronchitis) - Bronx NY

Within 50 Miles

Pediatric Depression - Mount Kisco NY

Type 2 Diabetes - New Windsor NY

Heart Failure After Heart Attack - Morristown NJ

Atrophic Vaginitis - Plainsboro NJ

Type 2 Diabetes - New Windsor NY

High Cholesterol - Stamford CT

Asthma - Asbury Park NJ

Bacterial Vaginosis - Plainsboro NJ

Asthma in Children (Ages 5 - Asbury Park NJ

Anemia - Plainsboro NJ

Asthma - Edison NJ

Asthma - Ocean NJ

Asthma in Children (Ages 5-11) - Neptune NJ

Within 100 Miles

Endometriosis - Milford CT

Endometriosis - Stratford NJ

Endometriosis - Levittown PA

Endometriosis - Philadelphia PA

Obsessive Compulsive Disorder (OCD) - Norristown PA

Obsessive Compulsive Disorder (OCD) - Norristown PA

Memory Loss - Norristown PA

Adolescent Major Depression (Ages 12-17) - Cherry Hill NJ

Obsessive Compulsive Disorder (OCD) - New Haven CT

Type 2 Diabetes - Waterbury CT

Type 2 Diabetes - Toms River NJ

Adolescent Depression - Cherry Hill NJ

Bipolar Disorder - Cherry Hill NJ

Post-Traumatic Stress Disorder (PTSD) - Norristown PA

Multiple Sclerosis - Philadelphia PA

Multiple Sclerosis - Derby CT

Attention Deficit Hyperactivity Disorder (ADHD) - Cherry Hill NJ

Osteoarthritis of the Knee - Trenton NJ

Type 2 Diabetes - Hopewell Junction NY

Type 1 Diabetes - Trenton NJ

Type 1 Diabetes - Jenkintown PA

Depression - Cherry Hill NJ

Diabetic Gastroparesis - Poughkeepsie NY

High Cholesterol - Levittown PA

High Cholesterol - Philadelphia PA

High Cholesterol - Harleysville PA

High Cholesterol - Trenton NJ

High Cholesterol - Lansdale PA

Type II Diabetes - Trenton NJ

COPD (Emphysema and Chronic Bronchitis) - Marlton NJ

Asthma - Middlebury CT